161 related articles for article (PubMed ID: 23835205)
1. Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma.
Mutter RW; Lok BH; Dutta PR; Riaz N; Setton J; Berry SL; Goenka A; Zhang Z; Rao SS; Wolden SL; Lee NY
Radiat Oncol; 2013 Jul; 8():173. PubMed ID: 23835205
[TBL] [Abstract][Full Text] [Related]
2. Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage.
Truong MT; Romesser PB; Qureshi MM; Kovalchuk N; Orlina L; Willins J
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):158-64. PubMed ID: 22300574
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric benefits of placing dose constraints on the brachial plexus in patients with nasopharyngeal carcinoma receiving intensity-modulated radiation therapy: a comparative study.
Jiang H; Lu H; Yuan H; Huang H; Wei Y; Zhang Y; Liu X
J Radiat Res; 2015 Jan; 56(1):114-21. PubMed ID: 25173085
[TBL] [Abstract][Full Text] [Related]
4. Brachial plexus dose tolerance in head and neck cancer patients treated with sequential intensity modulated radiation therapy.
Thomas TO; Refaat T; Choi M; Bacchus I; Sachdev S; Rademaker AW; Sathiaseelan V; Karagianis A; Mittal BB
Radiat Oncol; 2015 Apr; 10():94. PubMed ID: 25927572
[TBL] [Abstract][Full Text] [Related]
5. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer.
Amini A; Yang J; Williamson R; McBurney ML; Erasmus J; Allen PK; Karhade M; Komaki R; Liao Z; Gomez D; Cox J; Dong L; Welsh J
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e391-8. PubMed ID: 22284035
[TBL] [Abstract][Full Text] [Related]
6. Dose--volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol.
Chen AM; Wang PC; Daly ME; Cui J; Hall WH; Vijayakumar S; Phillips TL; Farwell DG; Purdy JA
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):771-7. PubMed ID: 24606846
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric analysis and clinical outcomes of brachial plexus as an organ-at-risk in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
Prakash BB; Yathiraj PH; Sharan TK; Singh A; Reddy AS; Chandraguthi SG; Subramanian RB; Nagesh J; Nair SS; Fernandes DJ; Mamidipudi VS
J Cancer Res Ther; 2019; 15(3):522-527. PubMed ID: 31169214
[TBL] [Abstract][Full Text] [Related]
8. Brachial plexus-associated neuropathy after high-dose radiation therapy for head-and-neck cancer.
Chen AM; Hall WH; Li J; Beckett L; Farwell DG; Lau DH; Purdy JA
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):165-9. PubMed ID: 22444998
[TBL] [Abstract][Full Text] [Related]
9. Validating the RTOG-endorsed brachial plexus contouring atlas: an evaluation of reproducibility among patients treated by intensity-modulated radiotherapy for head-and-neck cancer.
Yi SK; Hall WH; Mathai M; Dublin AB; Gupta V; Purdy JA; Chen AM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1060-4. PubMed ID: 21536393
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions.
Lindberg K; Grozman V; Lindberg S; Onjukka E; Lax I; Lewensohn R; Wersäll P
Acta Oncol; 2019 Aug; 58(8):1178-1186. PubMed ID: 31066326
[No Abstract] [Full Text] [Related]
11. Dose-volume modeling of brachial plexus-associated neuropathy after radiation therapy for head and neck cancer: in regard to Chen et al.
Beitler JJ; Jegadeesh NK; Higgins K
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):474-5. PubMed ID: 25304808
[No Abstract] [Full Text] [Related]
12. [Intensity-modulated radiotherapy of head and neck cancers. Dose constraint for spinal cord and brachial plexus].
Boisselier P; Racadot S; Thariat J; Graff P; Pointreau Y
Cancer Radiother; 2016 Oct; 20(6-7):459-66. PubMed ID: 27614529
[TBL] [Abstract][Full Text] [Related]
13. Brachial plexopathy after chemoradiotherapy for head and neck squamous cell carcinoma.
Platteaux N; Dirix P; Hermans R; Nuyts S
Strahlenther Onkol; 2010 Sep; 186(9):517-20. PubMed ID: 20814659
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
15. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.
Gensheimer MF; Liao JJ; Garden AS; Laramore GE; Parvathaneni U
Radiat Oncol; 2014 Nov; 9():255. PubMed ID: 25424729
[TBL] [Abstract][Full Text] [Related]
16. Tolerance of the Brachial Plexus to High-Dose Reirradiation.
Chen AM; Yoshizaki T; Velez MA; Mikaeilian AG; Hsu S; Cao M
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):83-90. PubMed ID: 28587056
[TBL] [Abstract][Full Text] [Related]
17. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
Schwartz DL; Hutcheson K; Barringer D; Tucker SL; Kies M; Holsinger FC; Ang KK; Morrison WH; Rosenthal DI; Garden AS; Dong L; Lewin JS
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1356-65. PubMed ID: 20646872
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer.
Chen AM; Hall WH; Li BQ; Guiou M; Wright C; Mathai M; Dublin A; Purdy JA
Br J Radiol; 2011 Jan; 84(997):58-63. PubMed ID: 20858665
[TBL] [Abstract][Full Text] [Related]
19. Brachial plexopathy in apical non-small cell lung cancer treated with definitive radiation: dosimetric analysis and clinical implications.
Eblan MJ; Corradetti MN; Lukens JN; Xanthopoulos E; Mitra N; Christodouleas JP; Grover S; Fernandes AT; Langer CJ; Evans TL; Stevenson J; Rengan R; Apisarnthanarax S
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):175-81. PubMed ID: 22658442
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
